Manon Huizing

Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial

Géraldine Gebhart, Laetitia E. Lamberts, Zéna Wimana et al. · Annals of Oncology · 2015 · 341 citations · Full text

Breast Oncology, Oncology, Engineering +13

Pharmacokinetics of paclitaxel and metabolites in a randomized comparative study in platinum-pretreated ovarian cancer patients.

Manon Huizing, Anther Keung, Hilde Rosing et al. · Journal of Clinical Oncology · 1993 · 311 citations

Pharmacokinetics of paclitaxel and carboplatin in a dose-escalating and dose-sequencing study in patients with non-small-cell lung cancer. The European Cancer Centre.

Manon Huizing, Giuseppe Giaccone, Laurence J. van Warmerdam et al. · Journal of Clinical Oncology · 1997 · 181 citations

Initial experience with conservative treatment in cancer patients with osteonecrosis of the jaw (ONJ) and predictors of outcome

Tim Van den Wyngaert, Tom Claeys, Manon Huizing et al. · Annals of Oncology · 2008 · 137 citations · Full text

Bone Disease, Surgical Oncology, Oncology +10

High-performance liquid chromatographic procedures for the quantitative determination of paclitaxel (Taxol) in human urine

Manon Huizing, Hilde Rosing, F J Koopman et al. · Journal of Chromatography B Biomedical Sciences and Applications · 1995 · 113 citations

Human Urine, Medicinal Chemistry, Urology +13